Paper26213619
Personalized management of hepatocellular carcinoma based on molecular information: future prospects.
Goossens N and 1 other. Clin Liver Dis (Hoboken), 2015. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Personalized management of hepatocellular carcinoma based on molecular information: future prospects. Papers, record 26213619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26213619
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Personalized management of hepatocellular carcinoma based on molecular information: future prospects.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK099558 | NIDDK NIH HHS | United States | R01DK099558 | PubMed and NIH |
Source NIH RePORTER
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23268517 | Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. | JAMA | 2012 | https://conductscience.org/library/papers/23268517 | PubMed |
| 2 | 21374666 | Management of hepatocellular carcinoma: an update. | Hepatology | 2011 | https://conductscience.org/library/papers/21374666 | PubMed |
| 3 | 24462733 | A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. | Gastroenterology | 2014 | https://conductscience.org/library/papers/24462733 | PubMed |
| 4 | 19362088 | Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. | Gastroenterology | 2009 | https://conductscience.org/library/papers/19362088 | PubMed |
| 5 | 22873223 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. | Curr Cancer Drug Targets | 2012 | https://conductscience.org/library/papers/22873223 | PubMed |
| 6 | 18923165 | Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18923165 | PubMed |
| 7 | 24122861 | Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma. | Hepatology | 2014 | https://conductscience.org/library/papers/24122861 | PubMed |
| 8 | 24084770 | Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy. | Br J Cancer | 2013 | https://conductscience.org/library/papers/24084770 | PubMed |
| 9 | 20194845 | Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20194845 | PubMed |
| 10 | 18977053 | Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. | J Hepatol | 2009 | https://conductscience.org/library/papers/18977053 | PubMed |
| 11 | 24557838 | Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. | Science | 2014 | https://conductscience.org/library/papers/24557838 | PubMed |
| 12 | 25362482 | Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. | Nat Genet | 2014 | https://conductscience.org/library/papers/25362482 | PubMed |
| 13 | 25635347 | A new initiative on precision medicine. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25635347 | PubMed |
| 14 | 23519950 | Genomic profiling of cell lines for personalized targeted therapy for hepatocellular carcinoma. | Hepatology | 2013 | https://conductscience.org/library/papers/23519950 | PubMed |
| 15 | 23504622 | Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. | Hepatology | 2013 | https://conductscience.org/library/papers/23504622 | PubMed |
| 16 | 22535689 | Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. | Hepatology | 2012 | https://conductscience.org/library/papers/22535689 | PubMed |
| 17 | 24801353 | Development and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies. | PLoS One | 2014 | https://conductscience.org/library/papers/24801353 | PubMed |
| 18 | 23589557 | Genomics-driven oncology: framework for an emerging paradigm. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23589557 | PubMed |
| 19 | 25143343 | A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. | Gut | 2015 | https://conductscience.org/library/papers/25143343 | PubMed |
| 20 | 24375711 | Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. | Hepatology | 2014 | https://conductscience.org/library/papers/24375711 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29524828 | Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus. | Transl Oncol | 2018 | https://conductscience.org/library/papers/29524828 | PubMed |
| 29376136 | Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. | Hepatoma Res | 2018 | https://conductscience.org/library/papers/29376136 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| EPCAM | 4072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| GPC3 | 2719 | PubTator's text mining | https://conductscience.org/library/genes/2719 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26213619
GET https://conductscience.org/api/papers/v1/26213619/references?page=2